1. An agent for stimulating neuritogenesis of eye tissue containing N- (1-acetylpiperidin-4-yl) -4-fluorobenzamide or a pharmaceutically acceptable salt thereof. ! 2. An agent for stimulating corneal neuritogenesis containing N- (1-acetylpiperidin-4-yl) -4-fluorobenzamide or a pharmaceutically acceptable salt thereof. ! 3. The agent according to claim 2, which is used to improve corneal sensitivity, treat dry eye syndrome or treat corneal epithelial disorders. ! 4. An agent for stimulating retinal neuritogenesis containing N- (1-acetylpiperidin-4-yl) -4-fluorobenzamide or a pharmaceutically acceptable salt thereof. ! 5. The tool according to claim 4, which is used to improve with visual dysfunction. ! 6. The use of N- (1-acetylpiperidin-4-yl) -4-fluorobenzamide or a pharmaceutically acceptable salt thereof for the manufacture of an agent stimulating neuritogenesis of eye tissue. ! 7. The use of N- (1-acetylpiperidin-4-yl) -4-fluorobenzamide or a pharmaceutically acceptable salt thereof for the manufacture of an agent that stimulates corneal neuritogenesis. ! 8. The use according to claim 7, in which the agent that stimulates neuritogenesis of the cornea is used to improve the sensitivity of the cornea, treat dry eye syndrome and treat corneal epithelial disorders. ! 9. The use of N- (1-acetylpiperidin-4-yl) -4-fluorobenzamide or a pharmaceutically acceptable salt thereof for the manufacture of an agent that stimulates retinal neuritogenesis. ! 10. The use according to claim 9, in which the agent stimulating neuritogenesis of the retina is used to improve with visual dysfunction. ! 11. A method of stimulating neuritogenesis of eye tissue, comprising administering an effective amount of N- (1-acetylpiperidin-4-yl)
展开▼
